Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Substance Abuse Treatment, Prevention, and Policy
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2015

Open Access 01-12-2015 | Short Report

Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan

Authors: Yasuko Fuse-Nagase, Fukumi Saito, Toshie Hirohara, Happei Miyakawa

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2015

Login to get access

Abstract

Background

Spread of new psychoactive substances (NPS) is a worldwide problem. In Japan, NPSs with psychoactive ingredients are called as “dappou drugs” or “kiken drugs.” Their potential effect on the Japanese society cannot be ignored.

Findings

We conducted an awareness survey of So-called Dappou Drugs or Kiken Drugs among the students of Ibaraki University, a national university in Japan, in April 2014. 3976 students (2425 men, 1406 women and 145 unspecified) participated in this study. 2813 (70.7 %) respondents were aware of dappou drugs. Only 39.5 % of the respondents selected the option of “ingredients that cause delusions and/or hallucinations may be included” in dappou drugs. 23.4 % of the respondents selected “the number of (dappou drug) users requiring emergency hospitalization due to acute intoxication is increasing”. Of the respondents, 19 (0.5 %) reported that they had been invited to use dappou drugs previously, and 40 (1.0 %) had witnessed and/or heard of somebody close to them using the drugs. Those who drank alcohol every day and those who smoked had a higher chance of witnessing and/or hearing of somebody close to them using dappou drugs than those who did not drink or smoke, respectively.

Conclusions

Japanese university students do not have sufficient knowledge about dappou drugs or kiken drugs to protect themselves from potential drug misuse. It is both important and urgent to educate Japanese university students about the harmful effects of dappou drugs; in addition, it is important to provide such knowledge before the students are allowed to legally drink and smoke.
Literature
1.
2.
Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int. 2014;243:23–9.CrossRefPubMed
3.
Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging ‘incense’ and ‘bath salt’ phenomenon. Cleve Clin J Med. 2012;79(4):258–64.CrossRefPubMed
4.
5.
Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. "Bath salts" and "plant food" products: the experience of one regional US poison center. J Med Toxicol. 2013;9(1):42–8.PubMedCentralCrossRefPubMed
6.
7.
Burns L, Roxburgh A, Matthews A, Bruno R, Lenton S, Van Buskirk J. The rise of new psychoactive substance use in Australia. Drug Test Anal. 2014;6(7–8):846–9.CrossRefPubMed
8.
Corazza O, Simonato P, Corkery J, Trincas G, Schifano F. "Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Riv Psichiatr. 2014;49(2):89–94.PubMed
9.
Maxwell JC. Psychoactive substances--some new, some old: a scan of the situation in the U.S. Drug Alcohol Depend. 2014;134:71–7.CrossRefPubMed
10.
Kamijo Y, Takai M, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S, et al. A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med. 2014;53(21):2439–45.CrossRefPubMed
11.
Tanibuchi Y, Matsumoto T. [Problems around the “legal highs”(law-evading new psychoactive substances.)]. [Article Japanese] Seishinigaku. 2015;57(2):105–17.
12.
13.
Fuse-Nagase Y, Nishikawa T. Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N. N-diisopropyltryptamine abuser Addict Sci Clin Pract. 2013;8:9.CrossRefPubMed
14.
Tanibuchi Y, Matsumoto T, Kobayashi O, Wada K. Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients.] [Article in Japanese. Seishin Shinkeigaku Zasshi. 2013;115(5):463–76.PubMed
15.
16.
17.
Nakano T, Takeshita S, Saito F, Miyakawa H. [Awareness survey of illegal drugs such as Marijuana/Hashish among college students.] [Article in Japanese]. Jpn J School Health. 2012;54:218–26.
18.
Shimane T, Wada K, Mishima K, Fujiwara M. Association between risky drinking behaviors and risk groups of substance abuse: a study in Japanese college freshmen.] [Article in Japanese. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2009;44(6):649–58.PubMed
19.
20.
21.
Carhart-Harris RL, King LA, Nutt DJ. A web-based survey on mephedrone. Drug and Alcohol Depend. 2011;118(1):19–22.CrossRef
22.
Winstock A, Mitcheson L, Ramsey J, Davies S, Puchnarewicz M, Marsden J. Mephedrone: use, subjective effects and health risks. Addiction. 2011;106(11):1991–6.CrossRefPubMed
Metadata
Title
Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan
Authors
Yasuko Fuse-Nagase
Fukumi Saito
Toshie Hirohara
Happei Miyakawa
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2015
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-015-0035-0

Other articles of this Issue 1/2015

Substance Abuse Treatment, Prevention, and Policy 1/2015 Go to the issue

Research

Beyond recidivism: changes in health and social service involvement following exposure to drug treatment court

Research

The efficacy of a blended motivational interviewing and problem solving therapy intervention to reduce substance use among patients presenting for emergency services in South Africa: A randomized controlled trial

Research

Feasibility and initial efficacy of a culturally sensitive women-centered substance use intervention in Georgia: Sex risk outcomes

Research

Views about responsibility for alcohol addiction and negative evaluations of naltrexone

Short Report

Smoking cessation among transit workers: beliefs and perceptions among an at-risk occupational group

Research

At-risk and problem gambling among adolescents: a convenience sample of first-year junior high school students in Finland